Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety.

Lamivudine has been demonstrated safe and efficacious in the short term in a large cohort of children with chronic hepatitis B (CHB), but optimal duration of treatment has not been elucidated and limited data on the safety of long-term lamivudine administration have been reported. In addition, the d...

Full description

Bibliographic Details
Main Author: Jonas, M (author)
Other Authors: Little, N (author), Gardner, S (author), Ferreira, G (author), International Pediatric Lamivudine Investigator Group (author)
Format: article
Language:eng
Published: 2014
Subjects:
Hepatite B
Antivirais
Lamivudina
Criança
Hepatitis B virus
Child
Lamivudine
Online Access:http://hdl.handle.net/10400.10/1129
Country:Portugal
Oai:oai:repositorio.hff.min-saude.pt:10400.10/1129

Internet

http://hdl.handle.net/10400.10/1129

Similar Items